Phase 2 N=58 S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer
Fallopian Tube Cancer · Ovarian Cancer · Peritoneal Cavity Cancer
Primary: Overall Survival — 32 months
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=54 Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Infection, Human Immunodeficiency Virus · HIV Infections
Primary: Plasma Amprenavir (APV) AUC (0-tau[τ]) — 26.6; 64.51; 54.2; 26.22 Hr per microgram/milliliter (hr*µg/mL)
Phase 2 N=1,051 Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials
Hepatitis B Virus · HBV
Primary: Overall Study: Number of Participants With Death As Outcome, Any Adverse Event (AE), Grade 3-4 AEs, Serious Adverse Events (SAEs), and Discontinuations Due to AEs — 18…
Phase 2 N=100 An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia (BPH)
Primary: Change of IPSS at the 6th Week Compared With Baseline(Intention to Treat) — 7.26; 2.34 units on a scale — p=< 0.01
Phase 2 N=79 S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Leukemia
Primary: Continuous Complete Remission at 1 Year — 21 participants
Phase 2 N=73 Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer
Breast Cancer
Primary: Progression-free Survival (PFS) Rate: Percentage of Participants With PFS — 59.6; 90.5; 30.8; 81.0 percentage of participants
Phase 2 N=132 TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary
Ovarian Cancer
Primary: Twelve-month Progression-free Survival (PFS) Rate in Participants — 65.7 percentage of participants
Phase 2 N=265 A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Actinic Keratosis
Primary: Incidence of AEs Recorded Throughout the Study — 12; 12; 8; 11 participants
Phase 2 N=68 A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) Level — -0.15; -0.26 % HbA1c — p=0.745
Phase 2 N=3,317 Study of the Efficacy of Plain Soap and Water Versus Alcohol-based Rubs for Surgical Hand Preparation
Postoperative Wound Infection
Primary: Surgical Site Infection — 128; 127 Participants — p=<0.05
Phase 2 N=44 Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
Breast Cancer
Primary: Number of Patients With Pathologic Complete Response (pCR) — 19 participants
Phase 2 N=202 A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
Central Nervous System Tumors · Brain Tumors
Primary: Local Tumor Control — 0.966; 0.959; 1.000; 1.000 Proportion of patients
Phase 2 N=47 Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
Acute Leukaemia · Chronic Disease · Leukemia
Primary: Number of High Risk Pediatric Patients With Successful Sustained Donor Engraftments — 16; 18; 10 participants
Phase 2 N=76 Proton Beam Therapy for Treatment of Hepatocellular Carcinoma
Liver Cancer · Hepatocellular Carcinoma
Primary: 3-year Survival Without Tumor Progression for Patients Within the Milan Criteria — 60 percentage of participants
Phase 2 N=40 Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
Prostate Cancer
Primary: Compare the Biodistribution of 11C-acetate Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Tumor and Non Tumorous Regions of the Prostate — 4.4…